PCV114 Prescribing Patterns of Antihypertensive Medications among Diabetic Patients in the United States  by Mountford, W.K. & Covington, D.
OBJECTIVES: Antihypertensive medication and lifestyle modification are crucial
for adequate control of hypertension in the vast majority of patients with this
condition. Poor adherence to one or both of these treatment modalities, however,
oftentimes prevents achievement of goal blood pressure. The primary objective of
this studywas to examine predictors of receiving and adhering to antihypertensive
medication and lifestyle modification for the treatment of hypertension.
METHODS: This study included adult respondents from the 2009 Behavioral Risk
Factor Surveillance Systemwho reported being diagnosed by a health care provider
as having hypertension (n38,474). A multivariable logistic regression model was
estimated to identify independent predictors of receiving and taking antihyperten-
sive medications as prescribed, as well as receiving and adhering to a lifestyle
modification advise from a healthcare provider, including modification of eating
habits, physical exercise, reduction of alcohol consumption and salt intake. The
following potential predictors were examined: respondent’s sex, education, em-
ployment,marital status, health status, health insurance access, cigarette use, and
geographic location. RESULTS: Black and older (65 years) patients were more
likely to be advised by healthcare providers to take medications for manage-
ment of their hypertension compared to White and younger patients (O.R.1.71
and OR11.2, p0.003 and p0.0001 respectively). All minority patients (Black,
Native Americans, Asians, and Hispanics) were more likely to receive a recom-
mendation about low-sodium diet and reduction of alcohol consumption com-
pared to Whites (p0.001). With respect to adherence to medication manage-
ment and life-style modifications, minority patients appeared to be similar or
even more adherent than White patients after controlling for respondent
characteristics. CONCLUSIONS: Our results indicate demographic differences
with regards to adherence to therapeutic medication and lifestyle-modification for
treating hypertension which may, in part, be a consequence of differences in how
providers counsel and treat patients based on their socio-demographic character-
istics.
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OBJECTIVES: Risk of cardiovascular disease death is 2-4 times higher in diabetics
than non-diabetics, and control of hypertension reduces this risk by up to 50%.
While there are numerous drug classes available for hypertension treatment, the
American Diabetes Association (ADA) specifically recommends ACE inhibitors or
ARBs because they offer additional vascular benefits in diabetes. Further, the ADA
suggests that multi-drug therapy is usually required to achieve blood pressure
targets. The objective of this study is to examine the prescribing patterns of anti-
hypertensive medications among diabetics relative the ADA recommendations.
METHODS:Data from the 2008 National AmbulatoryMedical Care Survey (NAMCS)
was utilized to identify office visits involving diabetic patients. This nationally
representative sample of US physician-patient office visits utilizes a multi-staged
sampling technique to collect several demographic and clinical parameters on
patient visits as well as information on up to eight continuous or newly prescribed
medications. Diabetes was identified by a physician questionnaire regarding pres-
ence of patient comorbidities and medications were identified using US National
Drug Codes. RESULTS: Of the 28,741 office visits collected, 2,955 were among dia-
betic patients and 49.3% (n1,456) of the diabetic patients were prescribed at least
one antihypertensive medication. ACE inhibitors were the most frequently pre-
scribed (40.9%), followed by beta blockers (39.4%), diuretics (30.2%), and calcium
channel blockers (20.5%). ARBs were less frequently prescribed (20%). Over half
(51.9%) were prescribed 2 or more hypertensive medications. CONCLUSIONS:
Based on data from the National Ambulatory Medical Care Survey, it appears that
ADA recommendations for hypertensive therapy in diabetics are being followed
with regard to ACE inhibitors and polytherapy. ARBs, however, appear less com-
mon in the population with other antihypertensive classes being prescribed more
frequently. Future studies involving longitudinal data are needed to evaluate
trending in the adherence to ADA recommendations for hypertensive therapy.
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OBJECTIVES: Readmission rates in the US following acute myocardial infarction
(AMI) remain high despite intensive medical therapy. This study evaluated the
association between antiplatelet therapy, aspirin  clopidogrel and the short and
long term readmission rates in patients whowere hospitalized for AMI.METHODS:
Patients with an index hospitalization for AMI in 2007–2009 and also received in-
hospital aspirin  clopidogrel were selected based on diagnoses and pharmacy
records from 122 hospitals in a US electronic medical record database (Cerner’s
Health Facts). Readmission for any reason or recurrent AMI within 30 days and 1
year following index AMI discharge was assessed based on hospital records. Mul-
tivariate logistic regressionwas used to estimate the association between readmis-
sion and in-hospital antiplatelet therapy, adjusted for age, gender, comorbidities,
AMI type, and coronary revascularization during index hospitalization. RESULTS:
Among 23,394 patients diagnosedwithAMI during index hospitalization (mean age
68.7 years; 58%male), 35% received aspirin alone and 65% received aspirin clopi-
dogrel in hospital. Patients on aspirin clopidogrel were younger, hadmore STEMI
diagnosis, higher rates for hypertension, dyslipidemia, diabetes, and PCI/stent
placement, but lower rates for atrial fibrillation, congestive heart failure, and cere-
brovascular disease than patients on aspirin alone (all p0.001). Patients who re-
ceived aspirin  clopidogrel had lower rates of readmission for any reason at 30
days (11.5% vs. 14.7%; adjusted odds ratio (OR)  0.89 [95% CI: 0.82, 0.97]) and at 1
year (33.2% vs. 37.3%; OR 1.06 [1.00, 1.13]) compared to aspirin alone. AMI-related
readmission rates were similar between in-hospital treatment regimens.
CONCLUSIONS: Both 30-day and 1-year readmission rates remain high post AMI
discharge, despite antiplatelet therapy using aspirin clopidogrel. In-hospital dual
antiplatelet therapy was associated with a reduction in short-term readmission
rate overall but not for long-term or recurrent AMI in this cohort.
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OBJECTIVES: To determine 30-day readmissions in patients with heart failure in
Arizona and to assess the association of sociodemographic characteristics, primary
payer, and case-mix risk adjustment with hospital readmissions. METHODS: The
2005 Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and
Utilization Project (HCUP) State Inpatient Database (SID) for Arizona was used. The
HCUP revisit files were utilized to identify 30-day same diagnosis-related group
(DRG) readmissions for heart failure and shock (DRG 127). Hospital dischargeswere
included if age 65 years with patient residence in Arizona, and excluded if a
diagnosis was missing or was for end stage renal disease (ESRD). Index events to
determine readmissions were identified if there was no DRG for heart failure and
shock in the 30-days prior to admission. Readmissions were reported at both pa-
tient-level and index-event level. The association of sociodemographic, primary
payer, and case-mix risk adjustment (i.e., Charlson index) on patient level hospital
readmissions were evaluated using multivariate logistic regression. RESULTS: In
2005, some 7828 discharges among 6688 patients were included in the analysis. A
total of 6,333 discharges qualified as index events. Patients were, on average,
79.9(7.9) yearswith a Charlson index of 2.6(1.4). Themajoritywerewhite (83.5%)
and female (53.0%). Inpatient mortality was 3.1%(n210). Mean discharges were
1.2(0.5) per patient and ranged from 1-7. The proportion of patients with at least
one readmission was 5.3% (n355) and 5.6% (n355) of 6,333 index events resulted
in a readmission. From the multivariate regression, only the Charlson index was
significantly associated with patients with 1 readmission (OR1.3; 95%CI: 1.3,
1.4). CONCLUSIONS: This investigation of hospital readmissions for heart failure
suggests that case-mix risk adjustment is a significant predictor of 30-day readmis-
sion. To better understand the influence of index events future analysis will con-
sider predictors of readmissions with an index event level analysis.
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OBJECTIVES: This survey investigated the implementation of hospital guidelines
for VTE prevention and protocols for VTE management/risk assessment and
thromboprophylaxis in hospitalized non-surgical, acutely-ill medical patients as
recommended by the American College of Chest Physicians.METHODS: As part of
a study of VTE in medically ill patients, identified from the HealthCore Integrated
Research Database, involving a random sample of 504 patients with medical
charts, a telephone survey of the 275 facilities in which these patients were hospi-
talizedwas conducted between June and September, 2011. An attemptwasmade to
contact Quality Management/Improvement (QM) coordinators at targeted institu-
tions. The survey consisted of a brief questionnaire (14 closed and 3 open-ended
questions) regarding the presence of hospital guidelines and risk assessment pro-
tocols. Results were summarized descriptively. RESULTS:We reached out to hos-
pital operators at all 275 facilities. Many of contacted persons, however, had diffi-
culty in identifying the QM department. Even when the correct department was
reached, approximately 90% of calls were routed directly to voicemail and repeated
calls (up to 3 calls at different times/days of week) were not returned.Wewere able
to directly speak with 30 (11%) QM coordinators, of whom, only 8 (27%) completed
the survey; 7 by telephone and 1 by email. Of the 8 (3%) hospitals that provided
responses, 76% had VTE-specific clinical guidance in place. Our low survey yield of
2.9% (8/275) is comparable with the response rate of 1.45% (21/1448) responding to
pertinent supplementary questions on VTE prevention in non-surgical patients
that were included in the survey conducted by the Joint Commission on Accredi-
tation for Healthcare Organizations (JCAHO) in 2009. CONCLUSIONS: QM depart-
ments in these hospitals are often unknown to hospital operators and QM coordi-
nators are generally hard to reach. Opportunities for improvement in the
implementation of VTE prophylaxis guidelines for hospitalized medically-ill pa-
tients exist.
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OBJECTIVES: To identify patient characteristics associated with filling a thien-
opyridine prescription (clopidogrel or prasugrel) following acute coronary syn-
drome (ACS) and percutaneous coronary intervention (PCI) in US health plans.
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